Immune System News and Research

RSS

Feeling stressed? reach for the sugar!

Researchers are now saying that reaching for a sugary snack in times of stress may not be such a bad idea after all.

16 Nov 2005

FLT-1 blockers, cutting the legs of leukaemia

Leukaemia is characterised by an uncontrolled growth of abnormal blood cells in the bone marrow (BM).

14 Nov 2005

Edifoligide no better than placebo for clogged veins

A new drug, edifoligide, designed to prevent the clogging of veins used in coronary bypass surgery was no more effective than a placebo, according to the results of a Phase III clinical trial led by researchers at Duke Clinical Research Institute (DCRI).

14 Nov 2005

Mayo Clinic provides new strategy for designing better treatments for juvenile dermatomyositis

Mayo Clinic researchers, working with colleagues at the University of Minnesota and University of Pittsburgh, are the first to describe a new role for a specialized cell of the immune system in children suffering from a rare muscle-damaging disease known as juvenile dermatomyositis (JDM).

14 Nov 2005

Bright light therapy may aid patients with depressive and bipolar disorders

A report in the November Cell Metabolism reveals powerful effects of light on the adrenal glands, a finding that might explain the broad benefits of bright light therapy for a variety of conditions, including sleep and depressive disorders, according to researchers.

14 Nov 2005

Why the bird flu virus H5N1 is so deadly to humans

A study published today in the open access journal Respiratory Research reveals that, in human cells, the virus can trigger levels of inflammatory proteins more than 10 times higher than the common human flu virus H1N1.

14 Nov 2005

People taking highly active antiretroviral therapy for HIV infection remain susceptible to tuberculosis

...though the risk is lower than for HIV-infected patients not on HAART, according to an article in the Dec. 15 issue of Clinical Infectious Diseases, now available online.

13 Nov 2005

New understanding of the disease process involved in atherosclerosis

The progression of the artery-clogging disease atherosclerosis is linked to the inability of specialized bone marrow cells to continuously repair damage to the arterial lining, Duke University Medical Center researchers have demonstrated.

13 Nov 2005

Maternal malaria and gravidity interact to modify infant susceptibility to malaria

Every year at least 30 million women in malaria-endemic areas of Africa become pregnant. Many of them develop placental malaria, a pregnancy-specific form of the disease, which frequently results in low birth weight of the child.

13 Nov 2005

Promising functional readouts of immunity in a blood-stage malaria vaccine trial

A malaria vaccine remains the most desired tool to combat the worsening malaria epidemic in many developing countries. Pierre Druilhe and colleagues (from the Institut Pasteur in Paris) have completed the first human trial of a vaccine based on MSP3, a protein present on the surface of the malaria parasite, with very encouraging results.

13 Nov 2005

Flu expert calls for mandatory vaccination of health care workers

Johns Hopkins' senior hospital epidemiologist and flu expert is calling for mandatory vaccination of all health care workers as the best means of protecting patients and hospital staff from widespread outbreaks of the viral illness.

10 Nov 2005

Vaccine for a type of blood cancer - follicular lymphoma

A team of researchers has demonstrated the clinical efficacy and benefits of a vaccine for a type of blood cancer, follicular lymphoma, amongst first time relapse patients. Specialists from two University of Navarre centres – the University Hospital and the Research Centre for Applied Medicine (CIMA) - have worked jointly since 2001 on the research.

9 Nov 2005

Chlamydia pneumoniae may cause vision problems

Researchers at the Massachusetts Eye and Ear Infirmary (MEEI) have found that Chlamydia pneumoniae, a bacterium linked to heart disease and capable of causing chronic inflammation, was present in the diseased eye tissue of five out of nine people with neovascular, or "wet," age-related macular degeneration (AMD).

7 Nov 2005

Tiny worms provide clues to new treatments for diabetes, asthma and hay fever

University of Edinburgh scientists, who have discovered that helminth parasites can exploit an 'Achilles heel' in our immune system, now hope to mimic the worms' survival tactics in a bid to beat infection.

7 Nov 2005

Research project to advance understanding of how cancer cells evade the immune system

A pre-clinical research project coordinated by The University of Manchester, which will advance understanding of how cancer cells evade the immune system, has been awarded nearly 12m Euro by the EU.

From The University of Manchester 7 Nov 2005

Hurricane Katrina leaves behind a cough as well as destruction

In the wake of hurricane Katrina some survivors have developed a cough now dubbed 'Katrina Cough'.

7 Nov 2005

Exposure to movie smoking accounts for smoking initiation among over one-third of U.S. adolescents

The first national study to look at the connection between smoking in movies and smoking initiation among adolescents shows that exposure to smoking in popular films is a primary risk factor in determining whether young people will start smoking.

7 Nov 2005

HIV antiretroviral therapy does help those in third world

With preliminary results from a study in Botswana, Harvard School of Public Health researchers have found that people with HIV-1 subtype C in resource-poor settings, who receive antiretroviral (ARV) therapy, can achieve comparable results to those in the developed world.

7 Nov 2005

HIV-positive patients have shorter survival periods while awaiting liver transplants

A new study on HIV-positive patients eligible for liver transplants found that their survival while waiting for a transplant is significantly shorter than patients who are HIV-negative.

7 Nov 2005

Study proves the effectiveness of Vfend for the treatment of candidemia

Using Vfend (voriconazole) for the treatment of nonneutropenic patients with candidemia, an often-fatal hospital-acquired bloodstream infection, is as effective as a regimen of two older antifungals and carries fewer serious side effects than that regimen.

7 Nov 2005

Immune System News and Research

Feeling stressed? reach for the sugar!

FLT-1 blockers, cutting the legs of leukaemia

Edifoligide no better than placebo for clogged veins

Mayo Clinic provides new strategy for designing better treatments for juvenile dermatomyositis

Bright light therapy may aid patients with depressive and bipolar disorders

Why the bird flu virus H5N1 is so deadly to humans

People taking highly active antiretroviral therapy for HIV infection remain susceptible to tuberculosis

New understanding of the disease process involved in atherosclerosis

Maternal malaria and gravidity interact to modify infant susceptibility to malaria

Promising functional readouts of immunity in a blood-stage malaria vaccine trial

Flu expert calls for mandatory vaccination of health care workers

Vaccine for a type of blood cancer - follicular lymphoma

Chlamydia pneumoniae may cause vision problems

Tiny worms provide clues to new treatments for diabetes, asthma and hay fever

Research project to advance understanding of how cancer cells evade the immune system

Hurricane Katrina leaves behind a cough as well as destruction

Exposure to movie smoking accounts for smoking initiation among over one-third of U.S. adolescents

HIV antiretroviral therapy does help those in third world

HIV-positive patients have shorter survival periods while awaiting liver transplants

Study proves the effectiveness of Vfend for the treatment of candidemia

Immunology eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News